Evidence map›Paper›PMID 29705032›Full record

ReviewJournal of magnetic resonance (San Diego, Calif. : 1997)2018

Diagnosis of multiple sclerosis through the lens of ultra-high-field MRI.

Pascal Sati

Registry-linked trialAbstract readReview
In one paragraph

Review in Journal of magnetic resonance (San Diego, Calif. : 1997), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05718947 (Multiple Sclerosis Lesion Characterization on Ultra-high-field MRI), which is not on this map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05718947 completednot on this mapstarted 2023, after this paper: background citation

Multiple Sclerosis Lesion Characterization on Ultra-high-field MRI: Comparative Pilot Study of 9.4 Vs 7 Vs 3 Tesla

TypeobservationalSponsorZuyderland Medisch CentrumRan2023 to 2024Enrolled10ConditionsMultiple SclerosisArmsBrain MRI (3T, 7T, 9.4T)
3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Imaging Outcomes for Phase 2 Trials Targeting Compartmentalized Inflammation.Multiple sclerosis (Houndmills, Basingstoke, England) · 2024
    Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Pascal SatiTranslational Neuroradiology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, 10 Center Drive MSC 1400, Building 10 Room 5C103, Bethesda, MD 20852, USA. Electronic address: satip@ninds.nih.gov.

Funding

Intramural NIH HHS Z99 NS999999
6 · The paper itself

Abstract

The long-standing relationship between ultra-high-field (7 T) MRI and multiple sclerosis (MS) has brought new insights to our understanding of lesion evolution and its associated pathology. With the recent FDA approval of a commercially available scanner, 7 T MRI is finally entering the clinic with great expectations about its potential added value. By looking through the prism of MS diagnosis, this perspective article discusses current limitations and prospects of 7 T MRI techniques relevant to helping clinicians diagnose patients encountered in daily practice.

Indexed as

Cerebral CortexElectromagnetic FieldsHumansMagnetic Resonance ImagingMultiple SclerosisReproducibility of ResultsBrainDiagnosisMagnetic Resonance ImagingMultiple sclerosisUltra-high-field

Identifiers

PMID29705032
PMCPMC6022748

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.